Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features


Autoria(s): Bergen, S.E.; Fanous, A.H.; Walsh, D.; O'Neill, Francis; Kendler, K.S.
Data(s)

01/04/2009

Resumo

We tested four genes [phenylalanine hydroxylase (PAH), the serotonin transporter (SLC6A4), monoamine oxidase B (MAOB), and the gamma-aminobutyric acid A receptor beta-3 subunit (GABRB3)] for their impact on five schizophrenia symptom factors: delusions, hallucinations, mania, depression, and negative symptoms. In a 90 family subset of the Irish Study of High Density Schizophrenia Families, the PAH 232 bp microsatellite allele demonstrated significant association with the delusions factor using both QTDT (F = 8.0, p = .031) and QPDTPHASE (chi-square = 12.54, p = .028). Also, a significant association between the GABRB3 191 bp allele and the hallucinations factor was detected using QPDTPHASE (chi-square 15.51, p = .030), but not QTDT (chi-square = 2.07, p = .560). (C) 2009 Elsevier B.V. All rights reserved.

Identificador

http://pure.qub.ac.uk/portal/en/publications/polymorphisms-in-slc6a4-pah-gabrb3-and-maob-and-modification-of-psychotic-disorder-features(065301c9-8d5c-4c28-b423-84adf6e2b500).html

http://dx.doi.org/10.1016/j.schres.2009.02.009

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Bergen , S E , Fanous , A H , Walsh , D , O'Neill , F & Kendler , K S 2009 , ' Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features ' Schizophrenia Research , vol 109 , no. 1-3 , pp. 94-97 . DOI: 10.1016/j.schres.2009.02.009

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2738 #Psychiatry and Mental health #/dk/atira/pure/subjectarea/asjc/2800/2803 #Biological Psychiatry
Tipo

article